These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37248127)

  • 1. [Impact of the French 2020 COVID-19 lockdown on the treatment and follow-up of patients with exudative age-related macular degeneration].
    Auger A; Khanna RK; Bonicel P; Pisella PJ; Le Lez ML
    J Fr Ophtalmol; 2023 Jun; 46(6):596-604. PubMed ID: 37248127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of monitoring wet age-related macular degeneration patients during Coronavirus disease 19 pandemic: A retrospective study of assessment of functional and structural outcomes.
    Tsiropoulos GN; Vallee R; Gallo Castro D; Ambresin A
    J Fr Ophtalmol; 2022 Oct; 45(8):852-859. PubMed ID: 35908993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neovascular recurrences in 42 treatment-naive eyes with neovascular age-related macular degeneration (AMD) followed for over 2 years].
    Bodénès F; Massé H; Lebreton O; Weber M
    J Fr Ophtalmol; 2021 May; 44(5):626-631. PubMed ID: 33840491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term impact of delayed follow-up due to COVID-19 lockdown on patients with neovascular age-related macular degeneration.
    Szegedi S; Ebner C; Miháltz K; Wachter T; Vécsei-Marlovits PV
    BMC Ophthalmol; 2022 May; 22(1):228. PubMed ID: 35596203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ranibizumab for exudative age-related macular degeneration: A five year study of adherence to follow-up in a real-life setting.
    Boulanger-Scemama E; Querques G; About F; Puche N; Srour M; Mane V; Massamba N; Canoui-Poitrine F; Souied EH
    J Fr Ophtalmol; 2015 Sep; 38(7):620-7. PubMed ID: 25913443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Real life visual and anatomic outcomes of aflibercept treatment for treatment-naive patients with exudative age-related macular degeneration].
    Duval MV; Rougier MB; Delyfer MN; Combillet F; Korobelnik JF
    J Fr Ophtalmol; 2017 Apr; 40(4):270-278. PubMed ID: 28341388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TEN-YEAR FOLLOW-UP OF PATIENTS WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS.
    Starr MR; Kung FF; Mejia CA; Bui YT; Bakri SJ
    Retina; 2020 Sep; 40(9):1665-1672. PubMed ID: 31725524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ranibizumab and exudative age-related macular degeneration: 5-year multicentric functional and anatomical results in real-life practice].
    Boulanger-Scemama E; Sayag D; Ha Chau Tran T; Quaranta-El Maftouhi M; Rumen F; Creuzot-Garcher C; Blanco Garavito R; Jung C; Souied E
    J Fr Ophtalmol; 2016 Oct; 39(8):668-674. PubMed ID: 27609025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IMPACT study: Impact of adherence to anti-VEGF intravitreal injections for macular disease during COVID 19-related confinement in France.
    Hurand V; Ducloyer JB; Baudin F; Aho S; Weber M; Kodjikian L; Devin F; Gabrielle PH; Creuzot-Garcher C; Massin P;
    Acta Ophthalmol; 2023 Feb; 101(1):91-99. PubMed ID: 35765939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the COVID-19 pandemic on neovascular age-related macular degeneration and response to delayed Anti-VEGF treatment.
    Yeter DY; Dursun D; Bozali E; Ozec AV; Erdogan H
    J Fr Ophtalmol; 2021 Mar; 44(3):299-306. PubMed ID: 33608176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a calculation model to estimate the impact of the COVID-19 pandemic lockdown on visual acuity in neovascular AMD.
    Stattin M; Haas AM; Ahmed D; Graf A; Krepler K; Ansari-Shahrezaei S
    Eur J Ophthalmol; 2022 Jul; 32(4):2312-2318. PubMed ID: 34726553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial utilization of aflibercept in exudative age-related macular degeneration.
    Cho H; Weber ML; Shah CP; Heier JS
    Eur J Ophthalmol; 2014; 24(4):576-81. PubMed ID: 24706352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interest of optical coherence tomography performed immediately before intravitreal injection of anti-VEGF in exudative AMD].
    Moyal L; Cohen SY; Pedinielli A; Semoun O; Lalloum F; Jung C; Souied E
    J Fr Ophtalmol; 2015 Sep; 38(7):573-9. PubMed ID: 25997681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twelve-month outcomes of intra-vitreal anti-VEGF agents for treatment-naïve neovascular age-related macular degeneration eyes: French data from the fight for retinal blindness!
    Lestable L; Gabrielle PH; Bron AM; Nguyen P; Creuzot-Garcher C
    J Fr Ophtalmol; 2020 Oct; 43(8):761-769. PubMed ID: 32622633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Worth changing? Clinical effects of switching treatment in neovascular age-related macular degeneration from intravitreal ranibizumab and aflibercept to bevacizumab in a region in southern Sweden.
    Bro T; Hägg S
    Eur J Ophthalmol; 2021 Jan; 31(1):144-148. PubMed ID: 31642333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fellow Eye Comparisons for 7-Year Outcomes in Ranibizumab-Treated AMD Subjects from ANCHOR, MARINA, and HORIZON (SEVEN-UP Study).
    Bhisitkul RB; Desai SJ; Boyer DS; Sadda SR; Zhang K
    Ophthalmology; 2016 Jun; 123(6):1269-77. PubMed ID: 26996339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TREATMENT DEFERRAL DURING COVID-19 LOCKDOWN: Functional and Anatomical Impact on Patients With Neovascular Age-Related Macular Degeneration.
    Montesel A; Gigon A; Giacuzzo C; Mantel I; Eandi CM
    Retina; 2022 Apr; 42(4):634-642. PubMed ID: 34907122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP).
    Rofagha S; Bhisitkul RB; Boyer DS; Sadda SR; Zhang K;
    Ophthalmology; 2013 Nov; 120(11):2292-9. PubMed ID: 23642856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal ranibizumab for neovascular age-related macular degeneration patients with good baseline visual acuity and the predictive factors for visual outcomes.
    Ozkaya A; Alkin Z; Osmanbasoglu OA; Ozkaya HM; Demirok A
    J Fr Ophtalmol; 2014 Apr; 37(4):280-7. PubMed ID: 24657215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the immediate impact of national lockdown on neovascular age-related macular degeneration and associated visual morbidity: an INSIGHT Health Data Research Hub for Eye Health report.
    Mollan SP; Fu DJ; Chuo CY; Gannon JG; Lee WH; Hopkins JJ; Hughes C; Denniston AK; Keane PA; Cantrell R
    Br J Ophthalmol; 2023 Feb; 107(2):267-274. PubMed ID: 34518162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.